BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 6197458)

  • 1. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE; Spits H
    J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal analysis of cytotoxic T lymphocytes (CTL) against autologous melanoma. Classification based on phenotype, specificity and inhibition by monoclonal antibodies to T cell structures.
    Hersey P; MacDonald M; Schibeci S; Burns C
    Cancer Immunol Immunother; 1986; 22(1):15-23. PubMed ID: 2423240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E; Te Velde AA; De Boer AJ; Weening RS; Fischer A; Borst J; Melief CJ; Figdor CG
    Eur J Immunol; 1992 Jun; 22(6):1467-75. PubMed ID: 1376259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.
    Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS
    Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human heart-infiltrating cells after transplantation. V. Suppression of donor-specific allogeneic responses by cloned T-cell lines isolated from heart biopsy specimens of patients after transplantation.
    Sell KW; Kanter K; Rodey GE; Wang YC; Ansari AA
    J Heart Lung Transplant; 1992; 11(3 Pt 1):500-10. PubMed ID: 1351744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cell lines recognize autologous and allogeneic melanomas with shared or cross-reactive HLA-A.
    Hayashi Y; Hoon DS; Park MS; Terasaki PI; Morton DL
    Cancer Immunol Immunother; 1992; 34(6):419-23. PubMed ID: 1373343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
    de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
    J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.
    LeMay LG; Kan-Mitchell J; Goedegebuure P; Harel W; Mitchell MS
    Cancer Immunol Immunother; 1993 Aug; 37(3):187-94. PubMed ID: 8101473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC).
    Wang P; Vánky F; Klein E
    Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocytes can mediate lysis of autologous melanoma cells by multiple mechanisms: evidence with a single T cell clone.
    Mazzocchi A; Anichini A; Castelli C; Sensi M; Poli F; Russo C; Parmiani G
    Cancer Immunol Immunother; 1990; 32(1):13-21. PubMed ID: 2149669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative and cytotoxic responses of human peripheral blood lymphocytes to autologous malignant effusions. An analysis at the clonal level.
    Roberts TE; Shipton U; Moore M
    Cancer Immunol Immunother; 1986; 22(2):107-13. PubMed ID: 2941144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens.
    Slingluff CL; Colella TA; Thompson L; Graham DD; Skipper JC; Caldwell J; Brinckerhoff L; Kittlesen DJ; Deacon DH; Oei C; Harthun NL; Huczko EL; Hunt DF; Darrow TL; Engelhard VH
    Cancer Immunol Immunother; 2000 Mar; 48(12):661-72. PubMed ID: 10752474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.
    Kan-Mitchell J; Liggett PE; Harel W; Steinman L; Nitta T; Oksenberg JR; Posner MR; Mitchell MS
    Cancer Immunol Immunother; 1991; 33(5):333-40. PubMed ID: 1831067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.
    Huang XQ; Mitchell MS; Liggett PE; Murphree AL; Kan-Mitchell J
    Cancer Immunol Immunother; 1994 Jun; 38(6):399-405. PubMed ID: 8205561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human heart-infiltrating cells after transplantation. VI. Differences in the cytokines produced by individual CD4+ cloned T-cell lines with apparently identical antiidiotype-like reactivity.
    Sell KW; Wang YC; Kanter K; Rodey GE; Mayne A; Ansari AA
    J Heart Lung Transplant; 1992; 11(3 Pt 1):511-21. PubMed ID: 1351745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of human-melanoma-specific T lymphocyte clones defining novel cytolytic targets with panels of newly established melanoma cell lines.
    Kirkin AF; Petersen TR; Olsen AC; Li L; thor Straten P; Zeuthen J
    Cancer Immunol Immunother; 1995 Aug; 41(2):71-81. PubMed ID: 7656272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of Epstein-Barr virus-specific cytotoxic T lymphocytes to lyse B cells transformed with the B95-8 strain is mapped to an epitope that associates with the HLA-B8 antigen.
    Misko IS; Schmidt C; Honeyman M; Soszynski TD; Sculley TB; Burrows SR; Moss DJ; Burman K
    Clin Exp Immunol; 1992 Jan; 87(1):65-70. PubMed ID: 1370774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays.
    Vose BM; White W
    Cancer Immunol Immunother; 1983; 15(3):227-36. PubMed ID: 6225511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.
    Whiteside TL; Miescher S; Hurlimann J; Moretta L; von Fliedner V
    Cancer Immunol Immunother; 1986; 23(3):169-78. PubMed ID: 3024832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.
    Rivoltini L; Barracchini KC; Viggiano V; Kawakami Y; Smith A; Mixon A; Restifo NP; Topalian SL; Simonis TB; Rosenberg SA
    Cancer Res; 1995 Jul; 55(14):3149-57. PubMed ID: 7541714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.